Literature DB >> 15658562

Keratomycosis in six horses in the United Kingdom.

J Sansom1, H Featherstone, K C Barnett.   

Abstract

Six horses with keratomycosis were examined and three different clinical expressions of the disease were recognised. The diagnostic work-up and response to treatment is described.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15658562     DOI： 10.1136/vr.156.1.13

Source DB:  PubMed          Journal:  Vet Rec        ISSN： 0042-4900            Impact factor:   2.695


  6 in total

1.  Equine pulmonary aspergillosis with encephalitic, myocardial, and renal dissemination.

Authors:  Selwyn Arlington Headley; Pedro Henrique de Carvalho; Luiz Fernando C Cunha Filho; Aline Artioli Machado Yamamura; Werner Okano
Journal:  Mycopathologia       Date:  2014-01-24       Impact factor: 2.574

Review 2.  Fungal infections in animals: a patchwork of different situations.

Authors:  Seyedmojtaba Seyedmousavi; Sandra de M G Bosco; Sybren de Hoog; Frank Ebel; Daniel Elad; Renata R Gomes; Ilse D Jacobsen; Henrik Elvang Jensen; An Martel; Bernard Mignon; Frank Pasmans; Elena Piecková; Anderson Messias Rodrigues; Karuna Singh; Vania A Vicente; Gudrun Wibbelt; Nathan P Wiederhold; Jacques Guillot
Journal:  Med Mycol       Date:  2018-04-01       Impact factor: 4.076

Review 3.  Optimal management of equine keratomycosis.

Authors:  Paula D Galera; Dennis E Brooks
Journal:  Vet Med (Auckl)       Date:  2012-03-12

4.  Equine keratomycoses in California from 1987 to 2010 (47 cases).

Authors:  Z Reed; S M Thomasy; K L Good; D J Maggs; K G Magdesian; N Pusterla; S R Hollingsworth
Journal:  Equine Vet J       Date:  2012-09-04       Impact factor: 2.888

5.  Equine infectious keratitis in Finland: Associated microbial isolates and susceptibility profiles.

Authors:  Minna P Mustikka; Thomas S C Grönthal; Elina M Pietilä
Journal:  Vet Ophthalmol       Date:  2019-07-31       Impact factor: 1.644

6.  Utility of systemic voriconazole in equine keratomycosis based on pharmacokinetic-pharmacodynamic analysis of tear fluid following oral administration.

Authors:  Norihisa Tamura; Atsushi Okano; Taisuke Kuroda; Hidekazu Niwa; Kanichi Kusano; Yoshikazu Matsuda; Kentaro Fukuda; Hiroshi Mita; Shunichi Nagata
Journal:  Vet Ophthalmol       Date:  2020-05-08       Impact factor: 1.644
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.